id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0016-0002,FDA,FDA-2001-N-0016,"Agency Information Collection Activities; Announcement of OMB Approval; Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report",Notice,Notice of Approval,2002-05-06T00:00:00Z,2002,5,,,2025-05-19T22:59:48Z,02-10791,0,0,09000064804b4ef5
FDA-2001-N-0016-0001,FDA,FDA-2001-N-0016,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Veterinary Adverse Drug Reaction, Lack of Effectiveness, Product Defect Report",Notice,30 Day Proposed Information Collection,2001-11-05T05:00:00Z,2001,11,2001-11-05T05:00:00Z,2001-12-06T04:59:59Z,2024-12-17T02:00:53Z,01-27641,0,0,09000064804b4ea8